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The rationale for the failure of dermatophytes
to invade the living tissue environment has long
been a subject of both speculation and investiga-
tive efforts. The fact that these organisms pro-
duce adequate growth on a seemingly endless
variety of substrates under a broad range of envir-
onmental conditions has only served to make
more obscure their confinement to the non-viable
keratinized components of the body. This ex-
quisite localization in the external dead skin and
its modifications has resulted in such terms as
necrophilia or keratinophilia being used to de-
scribe their metabolic activities and host-parasite
relationship. The dermatophytes, however, ap-
parently do not possess any distinctive physio-
logic attribute or peculiar enzymatic ability to
distinguish them from a multitude of saprophytic
fungi save perhaps their marked ability to evoke
a state of cutaneous hypersensitivity in the in-
fected host.
The possibility of the existence of a humoral
mechanism, by which resistance and suscepti-
bility to dermatophytoses might be explained,
has stimulated a significant amount of clinical
and laboratory investigation. Efforts to demon-
strate the presence of classical circulating anti-
bodies in the blood of individuals infected with
the superficial mycotic agents have been uni-
versally unsuccessful. Well-conceived plans to
produce demonstrable antibody response in a
variety of experimental animals has also resulted
in inconclusive results or failure. A somewhat
greater degree of success has been realized in
studies directed to detection of fungistatic ac-
tivity by the blood, however much of this work
is in variance as to the actual inhibitory efficacy
of serum. Ayres and Anderson in 1934 (1) re-
ported that the sera from individuals with tn-
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chophytid eruptions completely inhibited growth
of dermatophytes when the serum was used in a
concentration of 10 per cent in Sabouraud's me-
dium. Normal serum employed in the same con-
centration had no such effect on fungal growth.
The work of Peck, Rosenfeld, and Glick in 1940
(2) dealt with the fungistatic activity of serum,
and similar results were reported. Lewis and
Hopper (3) have observed that the addition of
normal serum to media retarded growth of der-
matophytes in a few instances. The addition of
sera obtained from individuals with dermato-
phytids to cultures produced a partial inhibition
of growth, but they were unable to obtain com-
plete fungistasis. Most recently, Lorincz, et at. (4)
showed that serum contains a dialyzable, water-
soluble, unstable substance which suppresses the
growth of dermatophytes. it is their opinion that
this serum factor plays a vital role in preventing
the invasion of living tissue by these fungi.
The research reported here was prompted, in
part, by the results of the work of Blank, et at.
(5) in which the pathogenesis of dermatophytes
was studied in cultured skin. It was observed that
the superficial fungi are unable to invade living
tissue due, in part, to the fungistatic effect of
the serum component in the nutrient medium
upon which the skin was grown. The absence of
sufficient concentration of serum in the tissue
culture environment permitted the dermato-
phytes to invade all layers and structures of the
living skin.
The present study is in the nature of a confirm-
atory investigation to show that the fungal
inhibitory activities of serum in cultured human
skin persist and are manifested in the in vitro
situation.
MATERIALS AND METHODS
The dermatophytes used in this study were in-
oculated into 50 ml. Erlenmeyer flasks containing
glucose-neopeptone-yeast extract broth. The ves-
sels were stationed upon a Gyrotary shaker plat-
form and rotated at room temperature at a speed
of 210 r.p.m. for from 5 to 7 days. In such an en-
vironment the fungi grow rapidly and form dis-
crete, spherical mycelial aggregates of remarkably
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uniform size. The use of these fungal pellets per-
mits a standardization of the inoculum, utiliza-
tion of the organism in an active metabolic state,
and the obviation of the time lag due to hyphal
repair or a state of dormancy. The pellets were
harvested from the flask, washed twice with
physiologic saline, and graded to secure uniform
diameter and mass.
Fungal pellets, grown in shaker culture, have
been used in industrial processes since the late
1930's and have proved an invaluable tool for
metabolic studies of the fungi. Foster (6) has
treated this method for growth of fungi in detail,
and Wyss, et at (7) are credited with first use of
this technic for the cultivation of dermatophytes.
The fungi used in this study were freshly-
isolated strains of Trichophyton mentagrophytes,
Trichophyton rubrum, and Candida albicans. The
dermatophytes chosen were strains which pro-
duced abundant microconidia in that these so-
called "gypseum" types produce large numbers of
very small pellets in shaker culture. The primary
culture of each organism was subcultured on 36
tubes of Sabouraud's agar. The resultant growth
was overlaid with sterile mineral oil and then
stored at 40 C. This procedure was designed to
perpetuate the organisms in a genetic and physio-
logic state closely approximating that of the
original isolate. For purpose of Gyrotary cultiva-
tion, a new preserved culture was employed for
each series to insure the use of a consistent fungal
type in the assay procedure.
Blood specimens to be assayed were collected
aseptically, centrifuged immediately upon retrac-
tion of clot, and the serum stored in a deep-freeze
until use. The serum assays were performed in
sterilized spot plates, each containing nine con-
cavities. Appropriate amounts of the freshly-
thawed serum were pipetted into the wells and
measured quantities of diluent then added to ob-
tain the desired serum concentration. Physiological
saline with 0.15 per cent glucose was generally
employed as the diluent. Each well contained a
final volume of 0.35 ml. After thorough mixing of
the well contents, a washed pellet was centered in
each concavity. Each plate had been sterilized
within a 150 mm. petri dish and a disk of heavy
blotting paper, subsequently saturated with
water, was included to retard evaporation.
The pellets were measured immediately after
inoculation in at least two diameters with a mi-
crometer eyepiece. The prepared plates were
placed in a 30° C. incubator with controlled hu-
midity. The plates were reexamined at 12-hour
intervals, and growth was calculated as the per-
centage increase over the original diameter of the
pellet. Experience showed that when a fungal
aggregate was removed from the Gyrotary shaker
a relaxation and expansion of the mycelial mass
occurred and, presumably, also a short period of
endogenous respiration and growth. For this rea-
son, only increases in excess of 20 to 25 per cent
in diameter were felt to represent significant
growth.
Similarly, the yeast Candida atbicans was grown
in Erlenmeyer flasks in Gyrotary culture. For use,
a 48-hour shaker culture was centrifuged at 2000
r.p.m. for 15 minutes and the sedimented cells
washed twice with cold saline. The original volume
was restored and the standard cell inoculum was
prepared as a 1.0 per cent cell suspension in buf-
fered saline.
Appropriate quantities of sterile fresh serum
and diluent were delivered into sterile 22 mm.
O.D. Lumetron colorimeter tubes and 0.05 ml. of
the standard yeast cell suspension added. The
total volume of serum, diluent, and cells in the
tubes amounted to 2.05 ml. The diluent was com-
posed of 4.0 per cent peptone, 0.25 per cent glucose,
0.1 per cent yeast extract, and 0.4 per cent sodium
chloride. No tube received more than 1.0 ml. of
diluent; in those tubes in which the serum plus
diluent did not total 2.0 ml. the deficiency in
volume was made up with saline. The inoculated
tubes were placed in a special rack on the Gyro-
tary platform and agitated at a speed of 180 r.p.m.
for 12 to 18 hours. At the conclusion of the incuba-
tion period the density of resultant cell growth
was determined turbidimetrically on the Lumetron
Colorimeter. The turbidity of each culture was
established in terms of per cent transmission as
compared with the serum control, diluent control,
and diluent-cell control.
RESULTS
The results obtained in the assay of 156 in-
dividual sera from normal subjects and from in-
dividuals infected with dermatophytes, as well
as specimens secured from patients with a va-
riety of diseases, showed that the great majority
of tested sera were characterized by marked
fungistatic activity. All but one of the sera sub-
jected to assay against both Trichophyton menta-
grophytes and Trichophyton rubrum demonstrated
inhibitory titers in the range between 20 and 60
per cent serum concentration for the initial 72
hours of observation. An analysis of the distri-
bution of the inhibitory titers of the 156 sera is
presented in Table 1. The mean inhibitory titer
for the group was established to be 44.7 per cent
serum concentration. The inhibitory titer of a
specimen was established at the lowest serum
concentration which held the increase in pellet
diameter under 25 per cent during the first 72
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TABLE 1
The distribuf ion of growth inhibitory titers o1' sera
assayed against dermatophytes









20 9 (5.8%) 9 (5.8%)
30 18 (11.5%) 27 (17.3%)
40 43 (28.2%) 70 (44.8%)
50 64 (41.0%) 134 (85.8%)
60 21 (13.5%) 155 (99.4%)
70 0 155 (99.4%)
80 1 (0.65%) 156 (100%)
hours of incubation. It is to be noted from Table 1
that 44.8 per cent of the sera had inhibitory ti-
ters at a serum concentration of 40 per cent or
less, whereas, in only about 14 per cent was a
concentration of 60 per cent or more required to
secure fungistasis. In most cases the serum con-
centration immediately below that of the in-
hibitory titer permitted growth in excess of 50
per cent. For sake of comparison, Sabouraud's
broth allowed a fungal pellet to increase its di-
ameter by 300 to 400 per cent in the same period
of time.
An examination of the histories provided by
the serum donors failed to furnish any conclusive
evidence that the inhibitory capacity of sera ob-
tained from those reporting no past or present
dermatophytoses possessed greater fungistatic
activity than those with a stated history of super-
ficial mycoses. The sera of 19 normal adult fe-
males demonstrated growth retardation titers
that averaged slightly higher than those observed
in 26 normal males. Assays of 17 sera of children
in the one- to two-year-old bracket indicated that
these sera were characterized by titers equal to
the higher average of adult sera. The serum ob-
tained from an unusual case of subcutaneous ab-
scesses and granuloma due to Trichophyton ru-
brum gave the lowest inhibitory titer of 156 tested
sera. This patient's serum failed to demonstrate
significant growth inhibition effect at concentra-
tions below 80 per cent. Incidental to this study
was the fact that the assay procedure lent itself
successfully to the determination of the level of
Amphotericin B in the blood of this patient during
a course of treatment with the antibiotic.
The effect of serum on dermatophytes was in
all cases limited to varying degrees of inhibition
of growth. Fungal aggregates which failed to evi-
dence growth in undiluted serum for 20 days at
6° C. developed normal colonies when trans-
ferred to Sabouraud's agar. This indicated that
the fungus in undiluted serum was merely re-
duced to a state of very low metabolic activity.
In most cases, after a pellet had been in the same
serum for more than 96 hours at 30° C., without
significant increase in size, a limited amount of
growth became evident. it is suggested that the
growth-restraining components in the serum may
be slowly metabolized by the introduced organ-
ism or undergo deterioration to deplete the levels
responsible for the initial inhibitory phase. This
recovery phenomenon was even more commonly
observed and dramatic in lower serum concentra-
tions. The resumption of growth after initial in-
hibition was largely prevented by periodic 72-
hour transfers to fresh serum.
Six sera from normal adult males were assayed
for inhibitory activity against the organism Tn-
chophyton mentagrophytes. Samples of each serum
were then dialyzed against distilled water for four
hours employing a micro-dialysis chamber. All
six specimens demonstrated a declination in in-
hibitory capacity during the 60-hour observa-
tion period. The results of this experiment are
shown in Table 2. Two of the sera showed that
an increase of 20 per cent in serum concentration
was required to obtain the equivalent degree of
inhibition noted in the pre-dialyzed serum. In
the remaining four samples, a 25 to 30 per cent
increase in serum per unit volume (0.35 ml.)
TABLE 2
The effect of dialysis and heat upon the fungistatic
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* Inhibition is defined as growth not in excess
of the 25 per cent allowed for relaxation and endo-
genous growth of a pellet.
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was needed to maintain activity equal to that
noted in the fresh material. Other aliquots of the
samples were heated for 30 minutes at 56° C.
and, in assay, demonstrated either no change in
activity or a loss not in excess of 15 per cent. In
the case of four other sera, the heat treatment
produced an increase in fungistatic activity when
the assay was set up immediately after removal
of the specimens from the water bath. When the
assay was repeated 48 hours later, however, a nor-
mal declination in the inhibitory titer was ob-
served. These findings confirm and amplify a
number of the prior observations made by Lorincz
etal.(4).
The dermatophyte assay plates were incubated
at 30° C. for it was felt that this temperature most
closely approximated that of the average skin
surface temperature. A number of assay pro-
cedures were set up in duplicate and one was in-
cubated at 30° C., the other at 37° C. The results
of this differential incubation procedure showed
that growth of dermatophytes was more actively
restrained at the higher temperature and inhibi-
tion was attained at lower serum concentrations.
This finding was not unexpected, for the practic-
ing mycologist is well aware of the fact that these
pathogens have an optimal growth rate in the
22° C. to 26° C. range. Imperfect fungi in general
are characterized by limited growth at high pre-
vailing temperatures. Comprehensive studies of
the cardinal temperature values of a large number
of species of fungi have indicated that very few
will tolerate a maximum temperature above 30
to 32° C. It need therefore be stated that the
very temperature of the body may be a potent
deterrent factor to growth of superficial mycotic
agents in the living tissue environment. These
findings would also tend to indicate that the
fungistatic complex of serum may apparently
have greater activity and efficacy at normal in-
ternal body temperature.
In the serum-saline dilutions in which restricted
growth of the dermatophytes did occur, there
was a constant failure in the formation of conidial
apparatus. At these concentrations, the growth
consisted exclusively of sterile mycelium and oc-
casional chains of arthrospore-like elements.
This growth pattern resembled in many ways
the mycelial structures seen characteristically in
human skin infected with dermatophytes. In
preparations maintained up to 144 hours this
effect was continued and in not a single case did
aerial mycelium form on the surface of the serum
dilution.
Subsequent to the observations made on the
inhibition of growth of dermatophytes by serum,
a modified assay technic was employed to deter-
mine if similar effects could be demonstrated for
the organism Candida albican.s. A series of tests
with normal adult blood showed that serum con-
centrations as low as 10 to 20 per cent, in a di-
luent which alone permitted luxuriant growth of
the yeast, sharply inhibited the growth and re-
production of the yeast. As a consequence of this
finding, the inhibitory levels manifested by ma-
ternal blood obtained immediately prior to de-
livery were compared with those obtained from
blood specimens taken from the umbilical cord.
The paired maternal and cord blood were diluted
to give serum concentrations ranging from the
undiluted state down to 5 per cent, in increments
of 10 per cent. Five such paired sera were as-
sayed and the average values obtained as to
growth inhibition of the yeast by the various
serum concentrations are presented in Figure 1.
As may be seen, the maternal sera persists at high
inhibitory level down to a serum concentration
as low as 30 per cent and their is still significant
activity at a serum concentration of only 10 per
cent. In marked contrast, however, is the in-
hibitory activity demonstrated by the serum ob-
tained from the umbilical cord. In these speci-
mens, the inhibitory effect closely parallels that
of the maternal serum until a concentration be-
low 80 per cent is reached, at which time there is a
precipitous declination of activity. The growth
impeding action of cord serum is lacking in con-
z
A
PER CENT SERUM CONCENTRATION
Fia. 1. Inhibition of the growth of C. albicans
by varying concentrations of five paired maternal
and umbilical cord sera.
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centrations below 60 per cent. In three of the
cord sera tested, the growth of C. albicans, as
determined by turbidity measurements, ex-
ceeded that observed in the serum diluent alone.
The same five paired maternal-cord sera em-
ployed in the preceding study were utilized in
assay against pellets of Trichophyton mentagro-
phytes. The results of this procedure showed that
in average the maternal sera inhibited the growth
of the dermatophyte for 72 hours at serum con-
centrations down to 40 per cent. Those obtained
with umbilical cord sera demonstrated inhibition
down to a concentration of 45 per cent serum.
The average inhibitory concentration of three
normal adult sera assayed concomitantly was 35
per cent. The saline-glucose diluent permitted a
17 per cent increase in pellet diameter during the
72-hour period of observation, whereas the growth
increase with a 0.25 per cent glucose, 5.0 per
cent neopeptone solution was 285 per cent. At 15
per cent serum concentration, the maternal sera
permitted an average increase of 64 per cent in
pellet diameter and the cord sera an 82 per cent
increase.
Although the lesser ability of cord and newborn
sera to restrain or inhibit the growth of C. albicans
may militate against a classical antibody mecha-
nism, an attempt was made to absorb the re-
sponsible factors from a high titered inhibitory
serum. Aliquots of the serum were heated in a
water bath at 56° C. for one hour, others were
rotated with a heavy inoculum of living yeast
cells for three hours, and the remainder were
treated with large volumes of heat-killed cells of
C. albicans for six hours at both 4° C. and 37°C.
These treated samples were centrifuged free of
cellular material and assayed for inhibitory con-
centration with the standard cell suspension. In
no case, was there any significant reduction in the
titer originally demonstrated by the untreated
serum.
A total of 27 serum specimens obtained from
infants ranging in age from 2 days to 2 years
have been examined for inhibitory activity
against C. albicans. The results obtained with
the limited number indicate that the humoral
factors responsible for the inhibition of growth
of the yeast are in low concentration during the
first 4 to 6 weeks of life. At the age of two to
three months an indication of an increase in the
titer is observed and from this point on the in-
crease in the inhibitory activity is rapid to reach
significant levels by the sixth month of life. The
values obtained in the ninth month of life ap-
proach those observed in the lower range of
tested maternal blood samples. By the time a
child has reached the age of 15 months to 2 years
the inhibitory activity of the serum is generally
equivalent to that demonstrated by normal adult
sera. In three instances blood from this age
bracket possessed concentrations above the aver-
age levels found in maternal blood.
DISCUSSION
it is our belief that the fungistatic capacity of
human serum does not find its origin or basis in
any one single component or factor. The results
obtained in this study and previous work by
others demonstrates that the serum is composed
of a number of diverse substances which, in total
and unified effect, retard or block metabolic ac-
tivities of dermatophytes. it is apparent that in
serum are factors that can be reduced or elimi-
nated by dialysis, other substances which can be
depleted or removed by heat and enzymatic ac-
tion of fungi, and certain non-specific, ill-defined
materials which occur in variable concentrations
and have yet to be elucidated. Equally important,
the serum itself is a complex organic fluid which,
to the dermatophytes and other fungi, may repre-
sent an adverse nutritive substrate in which to
grow. A comparison of the composition of the
serum with media used for cultivation of fungi
shows that a given volume of serum is very
limited in available glucose and the nitrogenous
components are in near-inhibitory concentration
and of a highly complex nature. A fungus placed
in serum must be required to produce a vast
array of enzymes to metabolize the diverse com-
ponents as well as to eliminate or reduce antago-
nistic factors or conditions. In the in vitro environ-
ment this is possible for the volume of the serum
is relatively small and the original composition
is not maintained or replenished. Under these
conditions the fungus can slowly alter the sub-
strate to a point where growth can occur. In the
tissues of the host, however, the serum volume
is great and the composition highly stable with
constant replenishment of normal constituents.
In this study the growth noted after a pellet had
been in the same serum for 96 hours or more was
partially ascribed to the foregoing reasons and,
in our opinion, established the validity of limiting
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the period of observation of serum effect to 72
hours.
A critical relationship exists between the vol-
ume of serum employed in an assay and the size
or mass of the fungal inoculum. In this study only
fungal aggregates with a diameter of between
1.0 and 1.2 mm. were used. Pellets much larger
than this range of size demonstrated growth in
many sera which either completely inhibited or
greatly restricted the growth of the standard size
pellet. Contrariwise, aggregates significantly
smaller than 1.0 mm. were often inhibited by
serum concentrations which demonstrated only
limited restrictive capacity against the standard
range. It should be mentioned that the very small-
est sized pellets probably greatly exceed the mass
of the infectious material with which host tissue
is confronted in nature. Pellets more than 14 days
of age, in a state of near dormancy or physiologic
old age, were inhibited by lower concentrations
of serum than young, physiologically active ag-
gregates. Similarly, a large pellet possesses
higher enzymatic production potential to thus
be able to more quickly reduce adverse effects of
high serum protein concentration and relieve an
inhibitory colloidal osmotic pressure. These ob-
servations indicate that the inhibitory activity
of a given volume of serum is directly related to
the mass of the fungal inoculum.
One of the important considerations confront-
ing one in this type of study is the formulation of
a diluent with which to prepare the various serum
concentrations. It was initially hoped that sera
would be found with very low inhibitory activity
so that this natural fluid could be employed as a
diluent. Although a total of 156 individual speci-
mens of serum were assayed, none was found
which did not possess sufficient inhibitory ac-
tivity to render it unsatisfactory for routine use.
Similarly, pooled rabbit, guinea pig, and horse
blood all demonstrated marked activity against
dermatophyte growth. Chick embryo extract,
on the other hand, proved to be one of the better
substrates for luxuriant growth of these fungi.
Many synthetic serum substitutes were employed
and evaluated. Included were such tissue culture
media as Hanks', Eagle's, Scherer's, 199, as well
as a number of original formulae compounded in
an attempt to closely approximate the normal
values found in human serum. None of these solu-
tions proved satisfactory as all were far more
complete and richer in available nutrients for
fungal growth than human serum. In practice
these serum substitutes obscured the effect of the
serum by functioning as potent growth stimulants
or highly favorable substrates. The most satis-
factory diluent, in our experience, proved to be
physiological saline containing 0.15 per cent
glucose. With this as a diluent it was possible to
titer out inhibitory factors without effecting a
drastic change in the nutritional nature of the
substrate. It was recognized that as one ap-
proached the lower serum concentrations there
was a progressive reduction in the amount of
nitrogen available for growth, however, even at
a serum concentration of but 15 per cent, the
nitrogen supply is roughly quantitatively equal
to that found in Sabouraud's agar. The added
glucose maintained a constant energy source ap-
proximately equal to that found in blood.
The effect of serum on growth of C. albican.s
is interesting and highly informative. From the
data presented it appears that the inhibition of
the yeast is based upon different mechanisms
than those responsible for the effect on the der-
matophytes. The fungistatic activity demon-
strated by the paired maternal-cord sera against
dermatophytes closely paralleled one another and
demonstrated near identical titer values; how-
ever, the maternal serum had high activity
against the yeast in low concentrations, but the
cord serum failed to contain the yeast growth
even when the serum concentration was quite
high. The mechanism responsible for the inhibi-
tion of C. albicans is still largely unknown to us
at the time of this writing. It is very tempting to
explain, at least in part, the high incidence of
thrush and moniiasis in infants on the basis of
these observations, but much more complete
studies are required. A study of the effect of hu-
man serum upon the growth of the subcutaneous
and systemic fungi is in its initial phases in our
laboratory and it is our hope that the results will
cast further light upon this little investigated but
very vital aspect of natural and acquired resist-
ance to mycotic agents.
SUMMARY
1. Human serum, in the vast majority of cases,
possesses considerable fungistatic activity for the
in vitro growth of dermatophytes.
2. The inhibitory capacity of serum for growth
of dermatophytes is present from birth and in a
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concentration roughly equivalent to that found
in the maternal blood.
3. The inhibitory titer of serum as measured
against the dermatophytes can be reduced sig-
nificantly by dialysis and to a much lesser degree
by heat (56° C.).
4. The effect of serum on dermatophytes is
strictly one of fungistasis and persists for periods
of time not in excess of 96 to 120 hours maximum.
Prolonged storage of the fungus in undiluted
serum at low temperatures (6° C.) showed the
effect was limited to inhibition.
5. The serum of normal adults demonstrates a
high capacity to inhibit the growth of Candida
albican.s. This capacity exists at a much reduced
level in sera obtained from the umbilical cord
and does not attain significant level in infants
until the third month of life.
6. The activity of serum against the growth of
C. albicans is not reduced to any great degree by
heat or short periods of incubation with living
or dead cells of the yeast.
REFERENCES
1. AYERS, S. AND ANDERSON, N. P.: Inhibition of
fungi in cultures by blood serum from pa-
tients with "phytid" eruptions. Arch.
Dermat. & Syph., 29: 537, 1934.
2. PECK, S. M., ROSENFELD, H. AND GLIcK, A. W.:
Fungistatic power of blood serum. Arch.
Dermat. & Syph., 42: 426, 1940.
3. LEWIS, G. M. AND HOPPER, M. E.: An Introduc-
tion to Medical Mycology. Year Book Pub-
lishers, 1948.
4. LoiuNcz, A. L., PRIESTLEY, J. 0. AND JACOB,
P. H.: Evidence for a humoral mechanism
which prevents growth of dermatophytes. J.
Invest. Dermat., 31: 15, 1958.
5. BLANK, H., SAGAMI, S., BOYD, C. AND ROTH,F. J., JR.: The pathogenesis of superficial
fungous infections in cultured human skin.
Arch. Dermat. & Syph., (in press).
6. FosTER, J. W.: Chemical Activities of Fungi.
Academic Press, Inc., 1949.
7. Wyss, 0., LUDwIG, B. J. AND JOINER, R. R.:
The fungistatic and fungicidal action of
fatty acids and related compounds. Arch.
Biochem., 7: 415, 1945.
DISCUSSION
DR. ALIN L. LOEINCZ (Chicago, Ill.): I en-
joyed this fine presentation very much and es-
pecially so because this work confirms observa-
tions reported to this society a year ago by my
associates and myself on the existence of potent,
non-antibody, antifungal activity in serum which
limits dermatophytic growth to those parts of the
skin lying outside the epidermal water barrier
zone which are not reached by body fluids. What
is of particular interest is that not one but prob-
ably a number of antifungal antibiotic substances
occur in serum. The real problem that remains is
to identify these substances. One might speculate
that possibly vitamin K or some of the steroids
in serum are among the antifungal factors in
question.
In connection with the suggestion which has
been made that fungal metabolism destroys the
antifungal activity of serum, I wonder if this is
so. In our studies the volume of serum used in
the presence of a standard fungal inoculum had
very little effect on the rate of disappearance of
antifungal activity. We rather felt that some oxi-
dative or enzymatic mechanism going on in serum
independently of fungal metabolism, in time, led
to loss of serum antifungal activity.
Dn. J. WALTER WILSON (Los Angeles, Calif.):
If any of you still have any doubts about gamma
globulin being effective as a treatment for Tn-
chophyton rubrum infections, see Doctor Samuel
Becker, because under his supervision a patient
was given a quantity of gamma globulin which
would have exhausted the resources of almost
any person without the slightest observable bene-
fit.
Da. EARL G. MCNALL (Los Angeles, Cali-
fornia): I wish to compliment Dr. Roth on a
very stimulating presentation of the very little
known and poorly understood antifungal activity
of fresh serum. There are some similarities be-
tween polysaccharides derived from the cell walls
of C. albicans and the polysaccharides one ob-
tains from the walls of S. cerevisias. First of all,
the infra-red spectra of the two polysaccharides
are very similar, secondly they both contain
glucose and mannose. It is well established that
the outermost cell wall of S. cerevisiae is made
up of a beta-D 1,3 glucopyranoside polymer
which has a high affinity for properdin. This poly-
saccharide is the active constituent of zymosan,
the reagent which has traditionally been used in
immunology to bind properdin and inactivate the
3rd component of complement. We ran a series
of experiments to determine whether the cell walls
of C. albicans bound properdin. Interestingly
enough, the insoluble polysaccharide from C.
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albicans, although being more anti-complemen-
tary, binds properdin in a manner and extent
similar to yeast glucan. One of the similarities
between the properties of the fungistatic activity
studied in this paper and the phenomena observed
in the properdin system is that the fungistatic
nctivity of cord blood is extremely smell com-
pared to the activity of young healthy adults.
Likewise the properdin levels in cord sera and in
the sera of young infants are of a similar order of
magnitude to the observed fungistatic activity.
Although about 90% of the properdin activity is
destroyed by heating at 56° C. for 30 minutes,
well over 80% of this activity remains after heat-
ing at 50° C. so that it would bedifficult to exclude
properdin as the fungistatic material present in
the sera reported by Dr. Roth. This does not
however, exclude other fungistatic material
which may be present in normal serum. Dr.
Roth, have you absorbed sera with a large ex-
cess of zymosan to determine whether the fungi-
static activity of the supernatant sera decreased?
DR. F. J. ROTH (in closing): I am in agreement
with Dr. Lorincz in that we have observed a pro-
gressive self-depletion in the serum anti-fungal
activity with time and ascribe it to a normal oxi-
dative process. The only evidence we have con-
trary to this concept came as the result of a recent
experiment. Paired serum specimens were stored
at 4° C. for 14 days with and without contained
fungal pellets. At the conclusion of the storage
period the inhibitory titers were determined. The
sera that had contained the organism during re-
frigeration were characterized by a significant re-
duction in anti-fungal activity as compared with
that of the fresh sera and those stored without
pellets. These findings would tend to indicate that
the inhibitory factors may be either slowly me-
tabolized or absorbed by the dermatophytes.
In a collateral study we have observed that
the addition of human gamma globulin to either
normal serum or assay medium failed to increase
the inhibitory titer to any significant degree.
